- R&D
- Brighter future, by specialized research.
-
WLHF-005(Fatdizol®)
Metabolic disease
-
WLHF-005(Fatdizol®) is a new natural material that can help people with metabolic diseases such as obesity.
- Background
- The obesity rate in adults is steadily increasing, and one of three people was reported to obesity in 2016
-
Obesity could cause vascular diseases such as high blood pressure, hyperlipidemia, and stroke, and various diseases such as diabetes, sleep apnea, and fatty liver.
-
Skinny fat could look healthy on the outside. However, intra-abdominal fat accumulated obesity could be even more dangerous because it causes cardiovascular and cerebrovascular disease.
- WLHF-005 (Fatdizol) inhibits adipocyte size enlargement.
WLHF-005 (Fatdizol) reduces body fat by promoting fat oxidation, inhibiting adipocyte differentiation, inhibiting fat synthesis, and promoting energy consumption.
